Contact
Please use this form to send email to PR contact of this press release:
Tellus Therapeutics Awarded NINDS SBIR Funding for Development of TT-20 for Treatment of Neonatal Brain Injury
TO:
Jason Kralic
Tellus Therapeutics, Inc.
+1 919-491-4995